GrippePaysBasV1, Main, Exploration, bibRecord, 000065

The impact of national vaccination policy changes on influenza incidence in the Netherlands.

Identifieur interne : 000065 ( Main/Exploration ); précédent : 000064; suivant : 000066

The impact of national vaccination policy changes on influenza incidence in the Netherlands.

Auteurs : Scott A. Mcdonald [Pays-Bas] ; Liselotte Van Asten [Pays-Bas] ; Wim Van Der Hoek [Pays-Bas] ; Gé A. Donker [Pays-Bas] ; Jacco Wallinga [Pays-Bas]

Source :

Influenza and other respiratory viruses [ 1750-2659 ] ; 2016.

RBID : pubmed:26648343

Descripteurs français

KwdFr :
- Adulte d'âge moyen (MeSH), Femelle (MeSH), Grippe humaine (prévention et contrôle), Grippe humaine (virologie), Grippe humaine (épidémiologie), Humains (MeSH), Incidence (MeSH), Mâle (MeSH), Pays-Bas (épidémiologie), Politique de santé (MeSH), Programmes de vaccination (MeSH), Saisons (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Surveillance sentinelle (MeSH), Vaccination (statistiques et données numériques), Vaccins antigrippaux (MeSH).
MESH :
- prévention et contrôle : Grippe humaine.
- statistiques et données numériques : Vaccination.
- virologie : Grippe humaine.
- épidémiologie : Grippe humaine, Pays-Bas.
- Adulte d'âge moyen, Femelle, Humains, Incidence, Mâle, Politique de santé, Programmes de vaccination, Saisons, Sujet âgé, Sujet âgé de 80 ans ou plus, Surveillance sentinelle, Vaccins antigrippaux.

English descriptors

KwdEn :
- Aged (MeSH), Aged, 80 and over (MeSH), Female (MeSH), Health Policy (MeSH), Humans (MeSH), Immunization Programs (MeSH), Incidence (MeSH), Influenza Vaccines (MeSH), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Influenza, Human (virology), Male (MeSH), Middle Aged (MeSH), Netherlands (epidemiology), Seasons (MeSH), Sentinel Surveillance (MeSH), Vaccination (statistics & numerical data).
MESH :
- chemical : Influenza Vaccines.
- epidemiology : Influenza, Human, Netherlands.
- prevention & control : Influenza, Human.
- statistics & numerical data : Vaccination.
- virology : Influenza, Human.
- Aged, Aged, 80 and over, Female, Health Policy, Humans, Immunization Programs, Incidence, Male, Middle Aged, Seasons, Sentinel Surveillance.

Abstract

BACKGROUND

We assessed the impact of two major modifications of the Dutch National Influenza Prevention Programme--the introduction in 1997 of free-of-charge vaccination to persons aged ≥65 years and to high-risk groups (previously only advised, and not free of charge), and the lowering of the eligible age to 60 years in 2008--on the estimated incidence of influenza infection leading to influenza-like illness (ILI).

METHODS

Additive negative-binomial segmented regression models were fitted to ILI data from GP sentinel surveillance in two-eight-season intervals (1993/4 to 2000/1, 2004/5 to 2011/12, comparing pre- and post-policy-change periods within each interval), with laboratory virological reporting of samples positive for influenza or other ILI-causing pathogens as covariates.

RESULTS

For the 2008 policy change, there was a significant step decrease in influenza contribution considering all ages (=-111 per 100 positives; 95% CI: -162, -65·0), <60 years and 60-64 years age groups (B = -92·1 per 100; 95% CI: -134, -55·5; B = -5·2; 95% CI: -10·3, -1·2, respectively). There was no evidence for a decrease associated with the 1997 policy change targeting the ≥65 years age group.

CONCLUSIONS

In the Netherlands, a 56% reduction in influenza contribution was associated with the 2008 policy targeting 60-64 year-olds, but there was no effect of the earlier policy targeting ≥65-year-olds, for whom vaccination coverage was already rising before the policy change.

DOI: 10.1111/irv.12366
PubMed: 26648343
PubMed Central: PMC4746562

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000079
to stream Main, to step Curation: 000079

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The impact of national vaccination policy changes on influenza incidence in the Netherlands.</title>
<author><name sortKey="Mcdonald, Scott A" sort="Mcdonald, Scott A" uniqKey="Mcdonald S" first="Scott A" last="Mcdonald">Scott A. Mcdonald</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Van Asten, Liselotte" sort="Van Asten, Liselotte" uniqKey="Van Asten L" first="Liselotte" last="Van Asten">Liselotte Van Asten</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Van Der Hoek, Wim" sort="Van Der Hoek, Wim" uniqKey="Van Der Hoek W" first="Wim" last="Van Der Hoek">Wim Van Der Hoek</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Donker, Ge A" sort="Donker, Ge A" uniqKey="Donker G" first="Gé A" last="Donker">Gé A. Donker</name>
<affiliation wicri:level="3"><nlm:affiliation>NIVEL Primary Care Database, Sentinel Practices, Utrecht, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>NIVEL Primary Care Database, Sentinel Practices, Utrecht</wicri:regionArea>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wallinga, Jacco" sort="Wallinga, Jacco" uniqKey="Wallinga J" first="Jacco" last="Wallinga">Jacco Wallinga</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26648343</idno>
<idno type="pmid">26648343</idno>
<idno type="doi">10.1111/irv.12366</idno>
<idno type="pmc">PMC4746562</idno>
<idno type="wicri:Area/Main/Corpus">000079</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000079</idno>
<idno type="wicri:Area/Main/Curation">000079</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000079</idno>
<idno type="wicri:Area/Main/Exploration">000079</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The impact of national vaccination policy changes on influenza incidence in the Netherlands.</title>
<author><name sortKey="Mcdonald, Scott A" sort="Mcdonald, Scott A" uniqKey="Mcdonald S" first="Scott A" last="Mcdonald">Scott A. Mcdonald</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Van Asten, Liselotte" sort="Van Asten, Liselotte" uniqKey="Van Asten L" first="Liselotte" last="Van Asten">Liselotte Van Asten</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Van Der Hoek, Wim" sort="Van Der Hoek, Wim" uniqKey="Van Der Hoek W" first="Wim" last="Van Der Hoek">Wim Van Der Hoek</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Donker, Ge A" sort="Donker, Ge A" uniqKey="Donker G" first="Gé A" last="Donker">Gé A. Donker</name>
<affiliation wicri:level="3"><nlm:affiliation>NIVEL Primary Care Database, Sentinel Practices, Utrecht, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>NIVEL Primary Care Database, Sentinel Practices, Utrecht</wicri:regionArea>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wallinga, Jacco" sort="Wallinga, Jacco" uniqKey="Wallinga J" first="Jacco" last="Wallinga">Jacco Wallinga</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Influenza and other respiratory viruses</title>
<idno type="eISSN">1750-2659</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Female (MeSH)</term>
<term>Health Policy (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Immunization Programs (MeSH)</term>
<term>Incidence (MeSH)</term>
<term>Influenza Vaccines (MeSH)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Influenza, Human (virology)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Netherlands (epidemiology)</term>
<term>Seasons (MeSH)</term>
<term>Sentinel Surveillance (MeSH)</term>
<term>Vaccination (statistics & numerical data)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (prévention et contrôle)</term>
<term>Grippe humaine (virologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains (MeSH)</term>
<term>Incidence (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Pays-Bas (épidémiologie)</term>
<term>Politique de santé (MeSH)</term>
<term>Programmes de vaccination (MeSH)</term>
<term>Saisons (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
<term>Surveillance sentinelle (MeSH)</term>
<term>Vaccination (statistiques et données numériques)</term>
<term>Vaccins antigrippaux (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
<term>Netherlands</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term>
<term>Pays-Bas</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Health Policy</term>
<term>Humans</term>
<term>Immunization Programs</term>
<term>Incidence</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Seasons</term>
<term>Sentinel Surveillance</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Mâle</term>
<term>Politique de santé</term>
<term>Programmes de vaccination</term>
<term>Saisons</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Surveillance sentinelle</term>
<term>Vaccins antigrippaux</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b>
</p>
<p>We assessed the impact of two major modifications of the Dutch National Influenza Prevention Programme--the introduction in 1997 of free-of-charge vaccination to persons aged ≥65 years and to high-risk groups (previously only advised, and not free of charge), and the lowering of the eligible age to 60 years in 2008--on the estimated incidence of influenza infection leading to influenza-like illness (ILI).</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>Additive negative-binomial segmented regression models were fitted to ILI data from GP sentinel surveillance in two-eight-season intervals (1993/4 to 2000/1, 2004/5 to 2011/12, comparing pre- and post-policy-change periods within each interval), with laboratory virological reporting of samples positive for influenza or other ILI-causing pathogens as covariates.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>For the 2008 policy change, there was a significant step decrease in influenza contribution considering all ages (=-111 per 100 positives; 95% CI: -162, -65·0), <60 years and 60-64 years age groups (B = -92·1 per 100; 95% CI: -134, -55·5; B = -5·2; 95% CI: -10·3, -1·2, respectively). There was no evidence for a decrease associated with the 1997 policy change targeting the ≥65 years age group.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>In the Netherlands, a 56% reduction in influenza contribution was associated with the 2008 policy targeting 60-64 year-olds, but there was no effect of the earlier policy targeting ≥65-year-olds, for whom vaccination coverage was already rising before the policy change.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26648343</PMID>
<DateCompleted><Year>2016</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>10</Volume>
<Issue>2</Issue>
<PubDate><Year>2016</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Influenza and other respiratory viruses</Title>
<ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation>
</Journal>
<ArticleTitle>The impact of national vaccination policy changes on influenza incidence in the Netherlands.</ArticleTitle>
<Pagination><MedlinePgn>76-85</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/irv.12366</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We assessed the impact of two major modifications of the Dutch National Influenza Prevention Programme--the introduction in 1997 of free-of-charge vaccination to persons aged ≥65 years and to high-risk groups (previously only advised, and not free of charge), and the lowering of the eligible age to 60 years in 2008--on the estimated incidence of influenza infection leading to influenza-like illness (ILI).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Additive negative-binomial segmented regression models were fitted to ILI data from GP sentinel surveillance in two-eight-season intervals (1993/4 to 2000/1, 2004/5 to 2011/12, comparing pre- and post-policy-change periods within each interval), with laboratory virological reporting of samples positive for influenza or other ILI-causing pathogens as covariates.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">For the 2008 policy change, there was a significant step decrease in influenza contribution considering all ages (=-111 per 100 positives; 95% CI: -162, -65·0), <60 years and 60-64 years age groups (B = -92·1 per 100; 95% CI: -134, -55·5; B = -5·2; 95% CI: -10·3, -1·2, respectively). There was no evidence for a decrease associated with the 1997 policy change targeting the ≥65 years age group.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In the Netherlands, a 56% reduction in influenza contribution was associated with the 2008 policy targeting 60-64 year-olds, but there was no effect of the earlier policy targeting ≥65-year-olds, for whom vaccination coverage was already rising before the policy change.</AbstractText>
<CopyrightInformation>© 2015 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McDonald</LastName>
<ForeName>Scott A</ForeName>
<Initials>SA</Initials>
<AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>van Asten</LastName>
<ForeName>Liselotte</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>van der Hoek</LastName>
<ForeName>Wim</ForeName>
<Initials>W</Initials>
<AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Donker</LastName>
<ForeName>Gé A</ForeName>
<Initials>GA</Initials>
<AffiliationInfo><Affiliation>NIVEL Primary Care Database, Sentinel Practices, Utrecht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wallinga</LastName>
<ForeName>Jacco</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>02</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Influenza Other Respir Viruses</MedlineTA>
<NlmUniqueID>101304007</NlmUniqueID>
<ISSNLinking>1750-2640</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006291" MajorTopicYN="Y">Health Policy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017589" MajorTopicYN="Y">Immunization Programs</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N">Netherlands</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018571" MajorTopicYN="N">Sentinel Surveillance</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Influenza</Keyword>
<Keyword MajorTopicYN="N">influenza-like illness</Keyword>
<Keyword MajorTopicYN="N">statistical model</Keyword>
<Keyword MajorTopicYN="N">the Netherlands</Keyword>
<Keyword MajorTopicYN="N">vaccination policy</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2015</Year>
<Month>11</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>12</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>12</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>11</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26648343</ArticleId>
<ArticleId IdType="doi">10.1111/irv.12366</ArticleId>
<ArticleId IdType="pmc">PMC4746562</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Infect. 2007 Jun;54(6):530-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17097147</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2009 Jul 09;14(27):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19589332</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Infect Dis. 2007 Nov 30;7:141</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18047685</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2000 Jan 27;342(4):232-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10648764</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Epidemiol Infect. 2013 Oct;141(10):2196-204</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23217849</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Scand J Prim Health Care. 2000 Dec;18(4):237-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11205093</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Public Health. 2010 Nov;100(11):2248-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20864730</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect. 2006 Jan;52(1):37-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16368459</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2012 Sep 1;206(5):628-39</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22723641</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 1996 Sep;174 Suppl 1:S12-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8752285</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Public Health. 1981 Jan;71(1):38-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7258429</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Pharm Ther. 2002 Aug;27(4):299-309</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12174032</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Epidemiology. 2012 Nov;23(6):839-42; discussion 843-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23038110</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Epidemiol. 2008 Aug;61(8):803-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18495428</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2008 Oct 16;26(44):5567-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18722492</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prev Med. 2002 Oct;35(4):401-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12453719</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2011 Mar 17;16(11):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21435329</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2012 Sep 1;206(5):625-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22723644</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Intern Med. 2005 Feb 14;165(3):274-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15710789</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Open Forum Infect Dis. 2014 Sep 22;1(2):ofu086</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25734152</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2011 Nov;5(6):e513-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21668666</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Pays-Bas</li>
</country>
<region><li>Utrecht (province)</li>
</region>
<settlement><li>Utrecht</li>
</settlement>
</list>
<tree><country name="Pays-Bas"><noRegion><name sortKey="Mcdonald, Scott A" sort="Mcdonald, Scott A" uniqKey="Mcdonald S" first="Scott A" last="Mcdonald">Scott A. Mcdonald</name>
</noRegion>
<name sortKey="Donker, Ge A" sort="Donker, Ge A" uniqKey="Donker G" first="Gé A" last="Donker">Gé A. Donker</name>
<name sortKey="Van Asten, Liselotte" sort="Van Asten, Liselotte" uniqKey="Van Asten L" first="Liselotte" last="Van Asten">Liselotte Van Asten</name>
<name sortKey="Van Der Hoek, Wim" sort="Van Der Hoek, Wim" uniqKey="Van Der Hoek W" first="Wim" last="Van Der Hoek">Wim Van Der Hoek</name>
<name sortKey="Wallinga, Jacco" sort="Wallinga, Jacco" uniqKey="Wallinga J" first="Jacco" last="Wallinga">Jacco Wallinga</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippePaysBasV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000065 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000065 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippePaysBasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:26648343
   |texte=   The impact of national vaccination policy changes on influenza incidence in the Netherlands.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:26648343" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippePaysBasV1

This area was generated with Dilib version V0.6.35.
Data generation: Mon Aug 10 10:18:30 2020. Site generation: Sat Mar 27 13:53:34 2021

	Serveur d'exploration sur la grippe aux Pays-Bas
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la grippe aux Pays-Bas

The impact of national vaccination policy changes on influenza incidence in the Netherlands.

The impact of national vaccination policy changes on influenza incidence in the Netherlands.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki